RADNET INC (RDNT) Stock Fundamental Analysis

NASDAQ:RDNT • US7504911022

72.09 USD
+2.08 (+2.97%)
At close: Feb 26, 2026
72.09 USD
0 (0%)
After Hours: 2/26/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall RDNT gets a fundamental rating of 3 out of 10. We evaluated RDNT against 101 industry peers in the Health Care Providers & Services industry. While RDNT is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, RDNT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • RDNT had positive earnings in the past year.
  • In the past year RDNT had a positive cash flow from operations.
  • Of the past 5 years RDNT 4 years were profitable.
  • RDNT had a positive operating cash flow in each of the past 5 years.
RDNT Yearly Net Income VS EBIT VS OCF VS FCFRDNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • With a Return On Assets value of -0.35%, RDNT perfoms like the industry average, outperforming 46.53% of the companies in the same industry.
  • RDNT has a Return On Equity of -1.20%. This is comparable to the rest of the industry: RDNT outperforms 50.49% of its industry peers.
  • The Return On Invested Capital of RDNT (2.08%) is comparable to the rest of the industry.
  • RDNT had an Average Return On Invested Capital over the past 3 years of 2.96%. This is significantly below the industry average of 8.95%.
Industry RankSector Rank
ROA -0.35%
ROE -1.2%
ROIC 2.08%
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
RDNT Yearly ROA, ROE, ROICRDNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • In the last couple of years the Profit Margin of RDNT has declined.
  • RDNT has a Operating Margin of 3.96%. This is comparable to the rest of the industry: RDNT outperforms 58.42% of its industry peers.
  • RDNT's Operating Margin has been stable in the last couple of years.
  • RDNT has a Gross Margin (21.33%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of RDNT has remained more or less at the same level.
Industry RankSector Rank
OM 3.96%
PM (TTM) N/A
GM 21.33%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
RDNT Yearly Profit, Operating, Gross MarginsRDNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RDNT is destroying value.
  • The number of shares outstanding for RDNT remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, RDNT has more shares outstanding
  • The debt/assets ratio for RDNT is higher compared to a year ago.
RDNT Yearly Shares OutstandingRDNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RDNT Yearly Total Debt VS Total AssetsRDNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • RDNT has an Altman-Z score of 1.98. This is not the best score and indicates that RDNT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • RDNT has a Altman-Z score of 1.98. This is comparable to the rest of the industry: RDNT outperforms 50.49% of its industry peers.
  • The Debt to FCF ratio of RDNT is 21.06, which is on the high side as it means it would take RDNT, 21.06 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 21.06, RDNT is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.01 is on the high side and indicates that RDNT has dependencies on debt financing.
  • RDNT's Debt to Equity ratio of 1.01 is on the low side compared to the rest of the industry. RDNT is outperformed by 61.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 21.06
Altman-Z 1.98
ROIC/WACC0.24
WACC8.57%
RDNT Yearly LT Debt VS Equity VS FCFRDNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • RDNT has a Current Ratio of 1.87. This is a normal value and indicates that RDNT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.87, RDNT is in the better half of the industry, outperforming 77.23% of the companies in the same industry.
  • RDNT has a Quick Ratio of 1.87. This is a normal value and indicates that RDNT is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.87, RDNT belongs to the best of the industry, outperforming 80.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.87
RDNT Yearly Current Assets VS Current LiabilitesRDNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • RDNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.70%.
  • The Earnings Per Share has been growing by 16.79% on average over the past years. This is quite good.
  • The Revenue has grown by 11.09% in the past year. This is quite good.
  • Measured over the past years, RDNT shows a quite strong growth in Revenue. The Revenue has been growing by 9.65% on average per year.
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
Revenue 1Y (TTM)11.09%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%

3.2 Future

  • Based on estimates for the next years, RDNT will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.27% on average per year.
  • RDNT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.97% yearly.
EPS Next Y-43.54%
EPS Next 2Y12.38%
EPS Next 3Y18.33%
EPS Next 5Y19.27%
Revenue Next Year10.42%
Revenue Next 2Y11.12%
Revenue Next 3Y10.57%
Revenue Next 5Y10.97%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
RDNT Yearly Revenue VS EstimatesRDNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
RDNT Yearly EPS VS EstimatesRDNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 189.71 indicates a quite expensive valuation of RDNT.
  • Based on the Price/Earnings ratio, RDNT is valued a bit more expensive than 61.39% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.21, RDNT is valued quite expensively.
  • With a Price/Forward Earnings ratio of 90.61, RDNT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of RDNT is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of RDNT to the average of the S&P500 Index (28.13), we can say RDNT is valued expensively.
Industry RankSector Rank
PE 189.71
Fwd PE 90.61
RDNT Price Earnings VS Forward Price EarningsRDNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RDNT is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, RDNT is valued a bit more expensive than the industry average as 60.40% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 107.17
EV/EBITDA 31.77
RDNT Per share dataRDNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as RDNT's earnings are expected to grow with 18.33% in the coming years.
PEG (NY)N/A
PEG (5Y)11.3
EPS Next 2Y12.38%
EPS Next 3Y18.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • RDNT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RADNET INC

NASDAQ:RDNT (2/26/2026, 8:00:02 PM)

After market: 72.09 0 (0%)

72.09

+2.08 (+2.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-09
Earnings (Next)03-03
Inst Owners97.98%
Inst Owner Change-0.76%
Ins Owners13.06%
Ins Owner Change0.76%
Market Cap5.58B
Revenue(TTM)1.97B
Net Income(TTM)-12.71M
Analysts85.71
Price Target93.59 (29.82%)
Short Float %10.97%
Short Ratio8.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)40.87%
Min EPS beat(2)-12.24%
Max EPS beat(2)93.99%
EPS beat(4)2
Avg EPS beat(4)-18.47%
Min EPS beat(4)-161.6%
Max EPS beat(4)93.99%
EPS beat(8)5
Avg EPS beat(8)155.06%
EPS beat(12)7
Avg EPS beat(12)122.76%
EPS beat(16)8
Avg EPS beat(16)-190.67%
Revenue beat(2)1
Avg Revenue beat(2)1.79%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)3.68%
Revenue beat(4)3
Avg Revenue beat(4)2.28%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)4.27%
Revenue beat(8)7
Avg Revenue beat(8)2%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)12
Avg Revenue beat(16)1.41%
PT rev (1m)0%
PT rev (3m)8.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.45%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.64%
Valuation
Industry RankSector Rank
PE 189.71
Fwd PE 90.61
P/S 2.83
P/FCF 107.17
P/OCF 21.69
P/B 5.27
P/tB 52.58
EV/EBITDA 31.77
EPS(TTM)0.38
EY0.53%
EPS(NY)0.8
Fwd EY1.1%
FCF(TTM)0.67
FCFY0.93%
OCF(TTM)3.32
OCFY4.61%
SpS25.45
BVpS13.68
TBVpS1.37
PEG (NY)N/A
PEG (5Y)11.3
Graham Number10.81
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -1.2%
ROCE 2.52%
ROIC 2.08%
ROICexc 2.81%
ROICexgc 4.81%
OM 3.96%
PM (TTM) N/A
GM 21.33%
FCFM 2.64%
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexgc growth 3Y-3.51%
ROICexgc growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 21.06
Debt/EBITDA 5.96
Cap/Depr 201.55%
Cap/Sales 10.41%
Interest Coverage 0.9
Cash Conversion 143.12%
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.87
Altman-Z 1.98
F-Score3
WACC8.57%
ROIC/WACC0.24
Cap/Depr(3y)125.7%
Cap/Depr(5y)126.7%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.7%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%11.11%
EPS Next Y-43.54%
EPS Next 2Y12.38%
EPS Next 3Y18.33%
EPS Next 5Y19.27%
Revenue 1Y (TTM)11.09%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%13.39%
Revenue Next Year10.42%
Revenue Next 2Y11.12%
Revenue Next 3Y10.57%
Revenue Next 5Y10.97%
EBIT growth 1Y-30.9%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year117.85%
EBIT Next 3Y43.2%
EBIT Next 5Y34.69%
FCF growth 1Y85.26%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y38.64%
OCF growth 3Y15.95%
OCF growth 5Y17.44%

RADNET INC / RDNT FAQ

Can you provide the ChartMill fundamental rating for RADNET INC?

ChartMill assigns a fundamental rating of 3 / 10 to RDNT.


Can you provide the valuation status for RADNET INC?

ChartMill assigns a valuation rating of 1 / 10 to RADNET INC (RDNT). This can be considered as Overvalued.


What is the profitability of RDNT stock?

RADNET INC (RDNT) has a profitability rating of 4 / 10.


Can you provide the financial health for RDNT stock?

The financial health rating of RADNET INC (RDNT) is 3 / 10.